Schedule 13D ownership disclosure
Semnur Pharmaceuticals Inc
Common Stock, par value $0.0001 · CUSIP: 81686G113
Event date: 2025-09-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Scilex Holding CompanyReported CIK 0001820190
Shares: 188,554,849 · Class: 79.89%
- Scilex, Inc.Reported CIK 0002084647
Shares: 181,804,849 · Class: 77.03%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-220480
- Form type
- SCHEDULE 13D
- Filer
- Scilex Holding Co
- CIK
- CIK 1820190
- Filed
- Sep 26, 2025
- Reporting period
- Sep 22, 2025
- Description
- Schedule 13D beneficial ownership